Drugs / LONGEVINEX
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT02321189 Comparator | Oct 2014 → May 2015 | eye disorder | Huazhong University of Science and Technology | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LONGEVINEX | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02321189 ↗ |
| Route | Oral | “let everyone of the participants oral 1 capsule containing 100 mg LONGEVINEX” NCT02321189 ↗ |